CONTEXT: Common pain conditions appear to have an adverse effect on work, but no comprehensive estimates exist on the amount of productive time lost in the US workforce due to pain. OBJECTIVE: To measure lost productive time (absence and reduced performance due to common pain conditions) during a 2-week period. DESIGN AND SETTING: Cross-sectional study using survey data from the American Productivity Audit (a telephone survey that uses the Work and Health Interview) of working adults between August 1, 2001, and July 30, 2002. PARTICIPANTS: Random sample of 28 902 working adults in the United States. MAIN OUTCOME MEASURES: Lost productive time due to common pain conditions (arthritis, back, headache, and other musculoskeletal) expressed in hours per worker per week and calculated in US dollars. RESULTS: Thirteen percent of the total workforce experienced a loss in productive time during a 2-week period due to a common pain condition. Headache was the most common (5.4%) pain condition resulting in lost productive time. It was followed by back pain (3.2%), arthritis pain (2.0%), and other musculoskeletal pain (2.0%). Workers who experienced lost productive time from a pain condition lost a mean (SE) of 4.6 (0.09) h/wk. Workers who had a headache had a mean (SE) loss in productive time of 3.5 (0.1) h/wk. Workers who reported arthritis or back pain had mean (SE) lost productive times of 5.2 (0.25) h/wk. Other common pain conditions resulted in a mean (SE) loss in productive time of 5.5 (0.22) h/wk. Lost productive time from common pain conditions among active workers costs an estimated 61.2 billion dollars per year. The majority (76.6%) of the lost productive time was explained by reduced performance while at work and not work absence. CONCLUSIONS: Pain is an inordinately common and disabling condition in the US workforce. Most of the pain-related lost productive time occurs while employees are at work and is in the form of reduced performance.
CONTEXT: Common pain conditions appear to have an adverse effect on work, but no comprehensive estimates exist on the amount of productive time lost in the US workforce due to pain. OBJECTIVE: To measure lost productive time (absence and reduced performance due to common pain conditions) during a 2-week period. DESIGN AND SETTING: Cross-sectional study using survey data from the American Productivity Audit (a telephone survey that uses the Work and Health Interview) of working adults between August 1, 2001, and July 30, 2002. PARTICIPANTS: Random sample of 28 902 working adults in the United States. MAIN OUTCOME MEASURES: Lost productive time due to common pain conditions (arthritis, back, headache, and other musculoskeletal) expressed in hours per worker per week and calculated in US dollars. RESULTS: Thirteen percent of the total workforce experienced a loss in productive time during a 2-week period due to a common pain condition. Headache was the most common (5.4%) pain condition resulting in lost productive time. It was followed by back pain (3.2%), arthritis pain (2.0%), and other musculoskeletal pain (2.0%). Workers who experienced lost productive time from a pain condition lost a mean (SE) of 4.6 (0.09) h/wk. Workers who had a headache had a mean (SE) loss in productive time of 3.5 (0.1) h/wk. Workers who reported arthritis or back pain had mean (SE) lost productive times of 5.2 (0.25) h/wk. Other common pain conditions resulted in a mean (SE) loss in productive time of 5.5 (0.22) h/wk. Lost productive time from common pain conditions among active workers costs an estimated 61.2 billion dollars per year. The majority (76.6%) of the lost productive time was explained by reduced performance while at work and not work absence. CONCLUSIONS:Pain is an inordinately common and disabling condition in the US workforce. Most of the pain-related lost productive time occurs while employees are at work and is in the form of reduced performance.
Authors: Ronny Bruffaerts; Gemma Vilagut; Koen Demyttenaere; Jordi Alonso; Ali Alhamzawi; Laura Helena Andrade; Corina Benjet; Evelyn Bromet; Brendan Bunting; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Yanling He; Hristo Hinkov; Chiyi Hu; Elie G Karam; Jean-Pierre Lepine; Daphna Levinson; Herbert Matschinger; Yoshibumi Nakane; Johan Ormel; Jose Posada-Villa; Kate M Scott; Matthew Varghese; David R Williams; Miguel Xavier; Ronald C Kessler Journal: Br J Psychiatry Date: 2012-04-26 Impact factor: 9.319
Authors: Andrea D Furlan; Fatemeh Yazdi; Alexander Tsertsvadze; Anita Gross; Maurits Van Tulder; Lina Santaguida; Joel Gagnier; Carlo Ammendolia; Trish Dryden; Steve Doucette; Becky Skidmore; Raymond Daniel; Thomas Ostermann; Sophia Tsouros Journal: Evid Based Complement Alternat Med Date: 2011-11-24 Impact factor: 2.629
Authors: Sarah E Tague; Gwenaëlle L Clarke; Michelle K Winter; Kenneth E McCarson; Douglas E Wright; Peter G Smith Journal: J Neurosci Date: 2011-09-28 Impact factor: 6.167
Authors: Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis Journal: Eur Spine J Date: 2018-02-01 Impact factor: 3.134
Authors: Seung Young Kim; Sung Woo Jung; Jung Wan Choe; Jong Jin Hyun; Young Kul Jung; Ja Seol Koo; Hyung Joon Yim; Sang Woo Lee Journal: Dig Dis Sci Date: 2016-09-30 Impact factor: 3.199